- Home
- GILD vs ENB Comparison
GILD vs ENB Comparison
Compare GILD & ENB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GILD | ENB |
|---|---|---|
| Founded | 1987 | 1949 |
| Country | United States | Canada |
| Employees | N/A | 14800 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Natural Gas Distribution |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 155.3B | 124.5B |
| IPO Year | 2003 | N/A |
Fundamental Metrics
Financial Performance| Metric | GILD | ENB |
|---|---|---|
| Price | $128.67 | $54.45 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 18 | 2 |
| Target Price | ★ $148.39 | $65.00 |
| AVG Volume (30 Days) | ★ 7.6M | 3.0M |
| Earning Date | 05-07-2026 | 05-08-2026 |
| Dividend Yield | 2.55% | ★ 5.13% |
| EPS Growth | ★ 1684.21 | N/A |
| EPS | ★ 1.61 | N/A |
| Revenue | ★ $24,689,000,000.00 | N/A |
| Revenue This Year | $4.68 | N/A |
| Revenue Next Year | $6.04 | $3.22 |
| P/E Ratio | $81.53 | ★ $21.67 |
| Revenue Growth | ★ 9.98 | N/A |
| 52 Week Low | $107.75 | $43.59 |
| 52 Week High | $157.29 | $58.45 |
Technical Indicators
Market Signals| Indicator | GILD | ENB |
|---|---|---|
| Relative Strength Index (RSI) | 51.39 | 45.16 |
| Support Level | $128.33 | $53.54 |
| Resistance Level | $137.35 | $55.66 |
| Average True Range (ATR) | 3.38 | 0.95 |
| MACD | 0.73 | -0.21 |
| Stochastic Oscillator | 57.18 | 37.89 |
Price Performance
Historical ComparisonAbout GILD Gilead Sciences Inc.
Gilead Sciences develops and markets therapies to treat and prevent life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of newer combination regimens that remain standards of care. Gilead is also growing its presence in the oncology market via acquisitions, led by CAR-T cell therapy Yescarta/Tecartus (from Kite) and breast and bladder cancer therapy Trodelvy (from Immunomedics).
About ENB Enbridge Inc
Enbridge owns extensive midstream assets that transport hydrocarbons across the US and Canada. Its pipeline network consists of the Canadian Mainline system, regional oil sands pipelines, and natural gas pipelines. The company also operates regulated natural gas utilities in the US and Canada, including Canada's largest natural gas distribution company. The firm has a small renewable energy portfolio primarily focused on onshore and offshore wind projects.